Betta Pharmaceuticals Hits Day Low of CNY 56.08 Amid Price Pressure

Betta Pharmaceuticals Co., Ltd. experienced significant market activity on October 14, 2025, with the stock declining by 14.03%. The stock reached an intraday low of CNY 56.08, reflecting a challenging trading day for the company. In terms of performance metrics, Betta Pharmaceuticals has shown a year-to-date increase of 8.18%, although it has underperformed compared to the China Shanghai Composite, which has gained 16.04% during the same period. Over the past month, the stock has decreased by 17.52%, while the one-week performance also reflects a decline of 12.68%. Despite the recent downturn, Betta Pharmaceuticals has demonstrated a notable annual return of 35.49%, significantly outperforming the China Shanghai Composite's 20.88% over the same timeframe. The company maintains a market capitalization of CNY 27,699 million and a price-to-earnings ratio of 72.00, indicating a high valuation relative to its earnings. Additionally, the stock offers a dividend yield of 0.30%, contributing to its overall financial profile.